Back to Agenda
Roundtable Discussion: The State of Real-World Evidence for Regulatory Decision-Making - Views from FDA, EMA, and PMDA
Session Chair(s)
Jingyu (Julia) Luan, PhD
Executive Regulatory Science Director, BioPharmaceuticals R&D
AstraZeneca, United States
Join the Real-World Evidence Community for a follow up round table discussion tied to session: The State of Real-World Evidence for Regulatory Decision-Making - Views from FDA, EMA, and PMDA (Monday, June 17 | 2:15pm - 3:15 PM PDT). Space is limited.
Have an account?